T. André, Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer, N Engl J Med, vol.350, issue.23, pp.2343-51, 2004.

T. Lecomte, T. André, F. Bibeau, B. Blanc, R. Cohen et al., « Cancer du côlon non métastatique » Thésaurus National de Cancérologie Digestive, 2019.

J. J. Biagi, Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis, JAMA, vol.305, issue.22, pp.2335-2377, 2011.

D. Sargent, A. Grothey, and R. Gray, Time to initiation of adjuvant chemotherapy and survival in colorectal cancer, JAMA, vol.306, issue.11, p.1199, 2011.

P. J. Hewett, Short-term outcomes of the Australasian randomized clinical study comparing laparoscopic and conventional open surgical treatments for colon cancer: the ALCCaS trial, Ann Surg, vol.248, issue.5, pp.728-766, 2008.

R. Veldkamp, Laparoscopic surgery versus open surgery for colon cancer: shortterm outcomes of a randomised trial, Lancet Oncol, vol.6, issue.7, pp.477-84, 2005.

A. M. Lacy, Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial, Lancet, vol.359, issue.9325, pp.2224-2233, 2002.

M. Braga, Laparoscopic versus open colorectal surgery: cost-benefit analysis in a single-center randomized trial, Ann Surg, vol.242, issue.6, pp.895-901, 2005.

C. Sabbagh, Is stenting as "a bridge to surgery" an oncologically safe strategy for the management of acute, left-sided, malignant, colonic obstruction? A comparative study with a propensity score analysis, Gastrointest Endosc, vol.258, issue.1, pp.747-61, 2013.

D. Mege, What is the Best Option Between Primary Diverting Stoma or Endoscopic Stent as a Bridge to Surgery with a Curative Intent for Obstructed Left Colon Cancer? Results from a Propensity Score Analysis of the French Surgical Association Multicenter Cohort of 518 Patients, Ann Surg Oncol, vol.26, issue.3, pp.756-764, 2019.

H. Kehlet, Fast-track colorectal surgery, Lancet, vol.371, issue.9615, pp.791-794, 2008.

B. Gignoux, Outpatient colectomy within an enhanced recovery program, J Visc Surg, vol.152, issue.1, pp.11-16, 2015.

K. Allart, C. Sabbagh, A. Dhahri, E. Chapuis-roux, L. E. Regimbeau et al., Fermeture de stomie par abord électif en chirurgie ambulatoire, résultats d'une étude prospective observationnelle

, Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial, Lancet Oncol, vol.13, issue.11, pp.1152-60, 2012.

M. Karoui, Neoadjuvant FOLFOX 4 versus FOLFOX 4 with Cetuximab versus immediate surgery for high-risk stage II and III colon cancers: a multicentre randomised controlled phase II trial--the PRODIGE 22--ECKINOXE trial, BMC Cancer, vol.15, p.511, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01212811

T. André, The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials 32

D. Dindo, N. Demartines, and P. A. Clavien, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, vol.240, issue.2, pp.205-218, 2004.

N. E. Kolfschoten, Focusing on desired outcomes of care after colon cancer resections; hospital variations in 'textbook outcome', Eur J Surg Oncol, vol.39, issue.2, pp.156-63, 2013.

L. Rinaldi, Laparoscopy could be the best approach to treat colorectal cancer in selected patients aged over 80 years: Outcomes from a multicenter study. Dig Liver Dis, vol.49, pp.84-90, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01798611

M. Hebbar, FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial, Ann Oncol, vol.26, issue.2, pp.340-347, 2015.

H. Sorbye, Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983), Ann Surg, vol.255, issue.3, pp.534-543, 2012.

D. Goéré, Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy, Ann Surg, vol.257, issue.1, pp.114-134, 2013.

L. Lei and Y. Zhang, Lack of Improvement in Scientific Integrity: An Analysis of WoS Retractions by Chinese Researchers, 1997.

S. Bekkar, Multicentre study of neoadjuvant chemotherapy for stage I and II oesophageal cancer, Br J Surg, vol.103, issue.7, pp.855-62, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01299289